Complement factor H (CFH) may be involved in age-related macular degeneration (AMD)

by Fundació Clínic per a la Recerca Biomèdica

A study carried out by Hospital Clínic-IDIBAPS has determined that complement factor H (CFH), a protein of the complement system, plays a role in AMD through its regulation of both inflammation and o...

Read more

Cellular push and pull, a key to the body's response to processes such as cancer

by Fundació Clínic per a la Recerca Biomèdica

Researchers from IDIBAPS, IBEC, UB and CIBERES discover how force dynamics affect cells and living tissues. The results give an insight into the critical mechanical processes that occur in different d...

Read more

CIC bioGUNE, ONCE Foundation and Ikerbasque sign an agreement to promote the research career of people with disabilities in the field of health sciences

by CIC bioGUNE

The successful candidates will conduct their research at CIC bioGUNE. The aim of the collaboration agreement is to improve equal opportunity, universal accessibility, inclusion and non-discrimination...

Read more

A study with over 700,000 patients enables the age of onset of different mental disorders to be established

by Fundació Clínic per a la Recerca Biomèdica

A study published in the journal Molecular Psychiatry, which is part of the Nature group, has conducted a meta-analysis with data from 192 epidemiological studies that include 708,561 patients, to det...

Read more

Josep Tabernero: 'The covid-19 has been a revulsive to value research and I hope that this will not change when the situation improves'

by GENESIS Biomed

Dr. Josep Tabernero is one of the most recognized and prestigious figures in the field of oncology. He is one of the most cited researchers and his healthcare work has earned him recognition as one of...

Read more

Nanomol Technologies receives Crédit d’Impôt Recherche (CIR) accreditation by the French Ministry of Higher Education and Research

by Nanomol Technologies

The French Ministry of Higher Education and Research has recently awarded the so-called CIR accreditation (Crédit d’Impôt Recherche) to Nanomol Technologies for the years 2020, 2021 and 2022.

Read more

World Cancer Day 2021

by Asphalion

Today is World Cancer Day, a day to raise awareness of cancer and to encourage its prevention, detection and treatment. At Asphalion we are committed to the fight against cancer. We have collaborated ...

Read more

Research is the main tool we have against cancer

by GENESIS Biomed

Cancer is the second biggest cause of death throughout the world today. Every year 9.6 million people die from it, 65% of them in low- and medium-income countries. Spain shows a similar trend to other...

Read more

Sílvia Carrasco: 'The COVID-19 pandemic has highlighted the importance of research and tech transfer'

by GENESIS Biomed

Research is crucial for the development of any country, but so is the transformation of that knowledge into products or applications that benefit society. Knowledge and technology transfer are among t...

Read more

Optimizing our 'new normal' to achieve exceptional innovation in 2021 and beyond

by CAS, a division of the American Chemical Society

The past year was unquestionably challenging for many of us. As I reflect on 2020, however, it is not only the challenges that will stick with me, but also the surprising amount that was achieved. The...

Read more

Lídia Ballell, R&D Scientist of Nanomol Technologies, Poster Prize at the SCN2 II Annual Conference of Nanomedicine

by Nanomol Technologies

Lídia Ballell, R&D Scientist of Nanomol Technologies, won the Poster Prize award at the SCN2 II Annual Conference of Nanoscience and Nanotechnology celebrated on 19 November 2020 and focused on the l...

Read more

Bioengineering and medtech to fight cancer

by Biocat

The combination of new bioengineering techniques and developments in the field of medical technology is destined to radically change cancer diagnoses and treatment. Close to 200 researchers, technicia...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

ORYZON reports results and corporate upd...

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage...

Photos Stream